Arkitekt Ventures

Arkitekt Ventures is an early stage venture capital firm based in New York, established in 2017, with a mission to enhance human health. The firm focuses on investing in the healthcare sector, particularly in innovative and disruptive healthcare delivery models. Arkitekt Ventures specializes in supporting founders developing digital health platforms and leveraging advanced technologies, including neurotechnology, bio-engineering, quantum applications, and artificial intelligence in medicine. Through its investments, the firm aims to foster breakthroughs that can significantly improve health outcomes.

Enke Bashllari

Founder and Managing Director

Pavan Choksi

Partner

David Eisenberg MD, MMCi

Venture Fellow

27 past transactions

Jimini Health

Pre Seed Round in 2024
Jimini Health is a mental health company dedicated to enhancing the effectiveness of mental health care globally. Established in 2023 by a team of experienced professionals in AI, biotech, and psychology, Jimini combines teletherapy with personalized AI support to create a comprehensive care model. Patients receive assistance from licensed clinicians and an AI therapy assistant named Sage, who work collaboratively to help individuals achieve their mental health goals. Jimini emphasizes the importance of clinical oversight and safety, ensuring that its technology is purpose-built and rooted in scientific principles. The company focuses on evidence-based practices and individualized care, particularly for those experiencing persistent anxiety. By integrating advanced technology with expert clinical guidance, Jimini aims to deliver high-quality mental health experiences that empower patients to take proactive steps in their treatment.

Mural Health

Seed Round in 2023
Mural Health is a technology company based in Berwyn, Pennsylvania, founded in 2022, that focuses on improving participation in clinical trials. The company develops solutions aimed at simplifying the process for individuals to engage in global research studies. Mural Health specializes in three key areas: transportation services to facilitate trial access, two-way messaging for effective communication between healthcare professionals and participants, and tools for collecting participant feedback. By addressing the common obstacles associated with enrolling in and remaining in clinical trials, Mural Health seeks to enhance the overall trial experience for both patients and caregivers.

Sollis Health

Series A in 2023
Sollis Health, previously known as Priority Private Care, provides comprehensive medical services focused on urgent and emergency care. The company offers members access to top-tier medical facilities and ER physicians who oversee their care from check-in to follow-up. With a commitment to personalized service, Sollis Health ensures that members receive attentive support and advanced diagnostic imaging. Their offerings include round-the-clock medical care, preventative health assessments, healthcare advocacy, and a network of selected specialists, all designed to enhance the patient experience during acute medical emergencies. The organization aims to deliver a seamless and superior healthcare experience, functioning like a personal doctor available at all times.

Nanite

Seed Round in 2023
Nanite is a biotechnology company focused on non-viral gene delivery through the development of programmable polymer nanoparticles. Utilizing an artificial intelligence-driven platform, Nanite combines advanced high-throughput experimental and computational methods to create tailored delivery vehicles. These vehicles are designed to effectively transport a wide range of genetic materials with specific targeting capabilities, facilitating research in functional chemistry and enhancing the design of therapeutically relevant gene delivery systems.

Elaborate

Seed Round in 2023
Elaborate is a clinical intelligence platform focused on reducing physician burnout by automating administrative tasks associated with patient care. The platform leverages patients' health data to optimize workflows, particularly in areas such as results management, referral processing, and visit preparation. By integrating with electronic medical records, Elaborate enhances communication between doctors and patients, allowing clinicians to deliver personalized, easy-to-understand summaries of lab results. This approach not only alleviates the administrative burden on healthcare providers but also promotes compliance and improves patient engagement, making it a trusted solution among health systems, academic medical centers, and multi-specialty groups.

Cofertility

Seed Round in 2022
Cofertility is a human-centered fertility ecosystem that provides egg donation and egg-freezing services for fertility care and third-party reproduction.

Certify

Series A in 2022
CertifyOS is a data intelligence platform focused on streamlining provider data management within the U.S. healthcare system. It provides an API-first and user interface agnostic solution that automates the entire provider network management lifecycle, including licensing, credentialing, and health plan enrollment. By integrating with numerous primary sources, CertifyOS offers near real-time verification and monitoring, facilitating efficient management of provider networks for insurance companies and virtual care providers. The platform aims to simplify and enhance the scalability of provider networking, positioning itself as a comprehensive resource for these critical operational needs.

Mable (Neurolytic Healthcare)

Seed Round in 2022
Neurolytic Healthcare Ltd. is a medical technology company based in Oxford, United Kingdom, specializing in the design, development, and manufacture of digital and genomic-based diagnostic tools and medical devices for migraine and related neurological disorders. Founded in 2016, the company focuses on personalized medicine by integrating genetic and biomarker data to enhance diagnosis and assist clinicians in determining optimal treatment strategies. Its product offerings include a diagnostic support tool, a pharmacogenetic test, and a mobile application designed to predict migraine events. By leveraging artificial intelligence, Neurolytic Healthcare aims to provide genomics-driven diagnostics and personalized treatment recommendations, helping patients find effective treatments while minimizing side effects and reducing the trial-and-error approach often associated with neurological care.

Canaery

Seed Round in 2022
Canaery is focused on developing a neural interface that digitizes the sense of smell to analyze the scent fingerprints of objects. This innovative technology is designed to identify hazardous compounds at critical locations such as ports and inspection points. By utilizing this neurotech device, clients can detect not only the presence of dangerous substances but also gain insights into the nature and condition of the objects being inspected.

Vibe Bio

Venture Round in 2022
Vibe Bio is a community of patients, scientists, and partners committed to identifying, funding, and developing promising treatments for rare diseases and empowering patient communities with unprecedented ownership over the process.

Culina Health

Seed Round in 2022
Culina Health provides personalized virtual nutrition counseling led by registered dietitians to enhance health outcomes for individuals with chronic conditions. The company focuses on making expert nutrition care accessible and affordable, offering culturally competent support tailored to the unique needs of each patient. Through its tele-nutrition platform, Culina Health assists individuals in managing their health by addressing their specific metabolic requirements, empowering them to make meaningful changes in their health habits and live balanced lives.

Handspring

Seed Round in 2022
Handspring is a provider of mental healthcare services focused on children, adolescents, and young adults. The company aims to enhance the family mental healthcare experience by integrating various modalities of care, including in-person sessions, digital platforms, and therapeutic devices. Handspring offers a range of services such as video sessions, skill-based exercises, parent education, medication management, and therapy guidance. By leveraging technology and partnering with health plans, Handspring seeks to make quality mental healthcare more accessible to families, ensuring that children receive timely and personalized therapy tailored to their unique needs. The approach emphasizes empowering young individuals with lifelong tools for growth and well-being.

Certify

Seed Round in 2022
CertifyOS is a data intelligence platform focused on streamlining provider data management within the U.S. healthcare system. It provides an API-first and user interface agnostic solution that automates the entire provider network management lifecycle, including licensing, credentialing, and health plan enrollment. By integrating with numerous primary sources, CertifyOS offers near real-time verification and monitoring, facilitating efficient management of provider networks for insurance companies and virtual care providers. The platform aims to simplify and enhance the scalability of provider networking, positioning itself as a comprehensive resource for these critical operational needs.

Sollis Health

Series A in 2022
Sollis Health, previously known as Priority Private Care, provides comprehensive medical services focused on urgent and emergency care. The company offers members access to top-tier medical facilities and ER physicians who oversee their care from check-in to follow-up. With a commitment to personalized service, Sollis Health ensures that members receive attentive support and advanced diagnostic imaging. Their offerings include round-the-clock medical care, preventative health assessments, healthcare advocacy, and a network of selected specialists, all designed to enhance the patient experience during acute medical emergencies. The organization aims to deliver a seamless and superior healthcare experience, functioning like a personal doctor available at all times.

NOVOS

Pre Seed Round in 2021
NOVOS is a Longevity supplements brand. Its goal is to help people live longer, healthier lives by developing science-based products that slow down the aging process.

Connie Health

Series A in 2021
Connie Health is a provider of medical advisory services focused on enhancing the experience of older Americans in navigating Medicare decision-making. The company utilizes an AI-driven technology platform, complemented by local Medicare experts, to assist individuals in maximizing their insurance benefits, optimizing prescription costs, and identifying healthcare providers in their vicinity. By offering personalized support, Connie Health empowers seniors to make informed healthcare choices, select the most appropriate healthcare plans, and effectively understand the benefits of their insurance coverage.

QSimulate

Seed Round in 2021
QSimulate is a Boston-based company that develops cloud-based quantitative simulation tools aimed at addressing complex challenges in the chemical and pharmaceutical industries. By harnessing the principles of quantum mechanics, QSimulate’s platform facilitates quantum molecular simulations, allowing clients to tackle industrial-scale problems more effectively. The tools offered by the company automate workflows, relieving computational scientists of routine tasks and thereby increasing productivity. This innovation enables organizations to accelerate their research and development processes, ultimately enhancing their capacity to innovate and solve critical issues in their fields.

Connie Health

Pre Seed Round in 2020
Connie Health is a provider of medical advisory services focused on enhancing the experience of older Americans in navigating Medicare decision-making. The company utilizes an AI-driven technology platform, complemented by local Medicare experts, to assist individuals in maximizing their insurance benefits, optimizing prescription costs, and identifying healthcare providers in their vicinity. By offering personalized support, Connie Health empowers seniors to make informed healthcare choices, select the most appropriate healthcare plans, and effectively understand the benefits of their insurance coverage.

HumanFirst

Seed Round in 2019
HumanFirst is a developer of an AI-powered software-as-a-service platform that aims to enhance patient-centered clinical trials through the use of precision digital measures, including digital biomarkers and electronic clinical outcome assessments. The platform, recognized as the largest of its kind, provides biopharma companies with valuable insights and validated evidence data to streamline drug development processes. By facilitating the integration of digital health technologies, HumanFirst supports pharmaceutical organizations in improving research efficiency and accelerating the deployment of innovative treatments. The platform has been utilized by 22 of the 25 largest pharmaceutical companies worldwide, underscoring its significance in advancing human-centric research and development.

Parsley Health

Series B in 2019
Parsley Health, Inc. offers personalized holistic healthcare services focused on addressing the root causes of diseases. By considering patients' personal histories, lifestyles, environments, and genetic factors, the company creates comprehensive health regimens that may include dietary changes, lifestyle adjustments, stress management techniques, supplements, botanical medicines, and prescription drugs. Their services encompass functional medicine assessments, personalized nutrition consultations, health coaching, specialized testing, bioidentical hormone therapy, and online access to labs and medical records. Parsley Health also provides various diagnostic tests and sells health-related products online. Founded in 2015 by Dr. Robin Berzin, M.D., the company operates clinics in New York City, Los Angeles, and San Francisco, integrating technology with wellness and preventive care to offer a subscription-based model that emphasizes chronic disease management and personalized treatment.

MEDIVIS

Seed Round in 2019
Medivis manufactures Software as a Medical Device (SaMD) for augmented reality surgical navigation. The company was founded in 2016 and is headquartered in the Flatiron district of New York City.

Paradromics

Seed Round in 2018
Paradromics, Inc. is focused on developing advanced brain-machine interfaces aimed at enhancing communication between the brain and external devices, particularly for individuals with neurodegenerative diseases. The company specializes in creating implantable systems that facilitate neural data decoding, allowing complex brain signals to be translated into data streams suitable for various neural prostheses. Paradromics is dedicated to providing high data-rate brain-computer interface technology that supports bidirectional data transmission, enabling patients to regain functionality lost due to neurological conditions. Founded in 2015, the company is headquartered in Austin, Texas.

BehaVR

Seed Round in 2018
BehaVR, LLC, established in 2016 and headquartered in Elizabethtown, Kentucky, operates a virtual reality platform designed to enhance practices and treatments within the healthcare sector. The company specializes in developing digital therapeutics for behavioral health, particularly at the intersection of behavioral health and chronic disease management. BehaVR's focus is on fostering skills such as stress resilience, emotional regulation, and self-efficacy, which aid individuals in coping with their conditions, adhering to care plans, and ultimately improving their overall health outcomes.

Cake

Seed Round in 2017
Cake offers a library of resources and interactive tools that use AI and data science to help consumers honor the entire cycle of life.

Darmiyan

Seed Round in 2017
Darmiyan has developed a novel, proprietary, patent-protected technology called The Virtual Microscope (Software Algorithm). Using a non-invasive routine clinical brain MRI scan, The Virtual Microscope technology looks into the human brain and localizes and quantifies cell distortion (neurodegeneration) in every voxel of brain MRI generating new brain maps. The first clinical product of this technology is BrainSee, an AI-powered algorithm that has completed a successful third-party validation in the US and Canada establishing a remarkable accuracy and consistency for prognosis of mild cognitive impairment. It is built on over 40 years of cutting-edge neuroscience research combined with advanced medical image analysis and AI, and has received official approval from the late Prof. Paul Greengard, Nobel Laureate in Physiology/ Medicine 2000.

Tia

Seed Round in 2017
Tia, Inc. is a health advisory platform focused on providing personalized and data-driven support for women's health and lifestyle. Founded in 2015 and headquartered in New York City with an additional office in San Francisco, Tia offers a mobile application that features services such as birth control recommendations, sexual health advice, symptom tracking, and the ability to locate nearby healthcare providers. The platform empowers women to manage their health by allowing them to schedule in-person appointments and access virtual care. Tia aims to address the unique needs of women in the healthcare system, recognizing that they control a significant portion of healthcare spending in the U.S. The company is supported by various venture funds, highlighting its commitment to building a healthcare model that prioritizes female patients.

Parsley Health

Seed Round in 2017
Parsley Health, Inc. offers personalized holistic healthcare services focused on addressing the root causes of diseases. By considering patients' personal histories, lifestyles, environments, and genetic factors, the company creates comprehensive health regimens that may include dietary changes, lifestyle adjustments, stress management techniques, supplements, botanical medicines, and prescription drugs. Their services encompass functional medicine assessments, personalized nutrition consultations, health coaching, specialized testing, bioidentical hormone therapy, and online access to labs and medical records. Parsley Health also provides various diagnostic tests and sells health-related products online. Founded in 2015 by Dr. Robin Berzin, M.D., the company operates clinics in New York City, Los Angeles, and San Francisco, integrating technology with wellness and preventive care to offer a subscription-based model that emphasizes chronic disease management and personalized treatment.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.